Paul R Kirchgraber Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul R Kirchgraber.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Paul R Kirchgraber for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14 2020 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 316 | 0 | 10,618 | |
| Feb 14 2020 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 263 | 0 | 10,934 | |
| Feb 14 2020 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Payment of Exercise | F | 187.51 | 88 | 16,501 | 5,061 | 5.1 K to 5.1 K (-1.71 %) |
| Feb 14 2020 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Buy | M | 0.00 | 316 | 0 | 5,149 | 4.8 K to 5.1 K (+6.54 %) |
| Feb 14 2020 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Payment of Exercise | F | 187.51 | 71 | 13,313 | 4,833 | 4.9 K to 4.8 K (-1.45 %) |
| Feb 14 2020 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Buy | M | 0.00 | 263 | 0 | 4,904 | 4.6 K to 4.9 K (+5.67 %) |
| Feb 11 2020 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 337 | 0 | 11,197 | |
| Feb 11 2020 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Payment of Exercise | F | 182.33 | 103 | 18,780 | 4,641 | 4.7 K to 4.6 K (-2.17 %) |
| Feb 11 2020 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Buy | M | 0.00 | 337 | 0 | 4,744 | 4.4 K to 4.7 K (+7.65 %) |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Option Exercise | A | 182.51 | 7,300 | 1,332,323 | 7,300 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Option Exercise | A | 0.00 | 1,680 | 0 | 11,534 |